5 news items
CV Sciences, Inc. Reports First Quarter 2024 Financial Results
CVSI
14 May 24
of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
CVSI
13 May 24
, Inc. filed a Current Report on Form 8-K which includes a description of the material terms of the transaction. Investors are encouraged to read
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
CVSI
8 May 24
. This material contains statements about expected future events and/or financial results that are forward looking in nature and subject to risks
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
CVSI
28 Mar 24
Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
CVSI
21 Mar 24
of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial
- Prev
- 1
- Next